AFX News Limited

Neurosearch starts phase I study on drug as new Parkinson's disease treatment

12.18.07, 4:55 AM ET
http://www.forbes.com/afxnewslimited...fx4451163.html

COPENHAGEN (Thomson Financial) - Danish pharmaceutical company Neurosearch AS said it has initiated phase I clinical studies of the drug candidate ACR343 with a view to develop it as a new treatment for Parkinson's disease.

'This achievement further highlights the very satisfactory...development seen in the pipeline programmes we took over with the acquisition of Carlsson Research (now Neurosearch Sweden) in October 2006,' Neurosearch chief executive Flemming Pedersen said.

As an effect of the study initiation, Neurosearch will make a 75 mln skr milestone payment to the former shareholders of Carlsson Research AB, the company said.

Neurosearch reiterated its previous financial guidance for 2007 of a 230-250 mln dkr loss before recognition of associates and other equity interests.

gustav.sandstrom@thomson.com

Hello, I'm new to your site. I'm 58 female and was diagnosed with PD in 2003 and doing pretty well so far. I'm interested in studies in the DC , Baltimore area. I do receive publications and read pdtrials.com. I belong to a local support group and start an exersise group for PD patients this week.I try to keep a positive outlook and make the best of each dayand some are better then others.